Skip to main content
. 2020 Feb 6;20:57. doi: 10.1186/s12887-020-1909-5

Table 1.

Cohort Characteristics

Patient Characteristics Hypoglycemia-related Characteristics
Patient ID Age at Survey (y) Age at Diagnosis (y) Diagnosis Ambulation status FVC % pred (age) Age of 1st episode of hypoglycemia (y) Caregiver estimate of # of lifetime hypoglycemic episodes # of hospital encounters reviewed Age of most recent hypoglycemic episode (y) History of FTT Supplemental Nutrition BMI percentileb
ID 1 7 0 LAMA2-RD c.2 T > C; c.47delG & muscle biopsy N 51% (5y) 5 5–8 6 6a Y 74
ID 2 6 0 LAMA2-RD c.7732 C > T & muscle biopsy N 1 16–25 2 5a Y G-Tube, GJ, TPN
ID 3 14 1 LAMA2-RD c.2538-1G > C & muscle biopsy N 86% (13y) 2 > 25 7 14a Y G-tube 82
ID 4 14 2 DNM2-RM c.1102G > A Y 1 > 25 4 3 N 60
ID 5 5 2 LAMA2-RD c.3976C > T; c.4523 + 1G > A & muscle biopsy N 4 < 5 4 5a
ID 6 14 1 TTN-RM/ CNM c.32854 G > C; c.37112-1G > A & muscle biopsy Y 44% (12y) 2 < 5 2 7 Y G-tube < 0.1
ID 7 7 0 TTN-RM c.92992A > G; c.19241C > A & muscle biopsy Y 104% (8y) 2 5–8 5 5 Y G-tube 48
ID 8 9 0 LAMA2-RD c.725G > A; c.7572 + 1G > T & muscle biopsy N 5 5–8 1 8 N G-tube
ID 9 17 1 COL6-RD COL6A3i15/e16;c.6157–9 _c.6177del30 & muscle biopsy N 26% (16y) 7 < 5 1 8 Y 0.2
ID 10 10 10 aDG muscle biopsy N 4 < 5 4 Y G-tube

ID identification, y years, Pred Predicted, FVC Forced Vital Capacity on Pulmonary Function Testing, BMI body mass index, RD related dystrophy, RM related myopathy, aDG alpha-dystroglycanopathy, Y Yes, N No, G-tube gastrostomy tube, GJ gastro-jejunostomy tube, TPN total parenteral nutrition, aHypoglycemia episodes ongoing at the time of data collection, bReported closest available to onset of hypoglycemia, − Not available